Insider Trading History of Lerer Rene

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Lerer Rene since 2006. The trader's CIK number is 1245352. At the time of the last reporting, Lerer Rene was the President & CEO of Magellan Health Inc. (stock ticker symbol MGLN). Also see all insider trading activities at Magellan Health Inc.



Yearly summary of insider trading at Magellan Health Inc (MGLN) by Lerer Rene

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 MGLN 0 $0 428,005 $25,696,713 22,683 $0
2012 MGLN 0 $0 0 $0 24,936 $0
2011 MGLN 0 $0 161,250 $8,127,095 24,106 $0
2010 MGLN 0 $0 70,000 $3,025,263 23,999 $0
2009 MGLN 0 $0 17,500 $700,262 20,325 $0
2008 MGLN 0 $0 0 $0 12,890 $0
2007 MGLN 0 $0 537,173 $18,365,547 5,623 $0
2006 MGLN 0 $0 41,031 $1,609,071 0 $0


Insider trading of Magellan Health Inc (MGLN) by Lerer Rene

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-12-06 MGLN Sale 6,700 61.62 412,840
2013-12-03 MGLN Sale 28,321 61.02 1,728,260
2013-11-29 MGLN Sale 32,000 61.35 1,963,136
2013-12-02 MGLN Sale 4,000 61.17 244,680
2013-11-27 MGLN Sale 40,100 60.83 2,439,122
2013-11-25 MGLN Sale 1,655 60.95 100,880
2013-11-26 MGLN Sale 3,400 60.66 206,244
2013-11-22 MGLN Sale 14,700 60.66 891,775
2013-11-18 MGLN Sale 15,215 61.41 934,277
2013-11-15 MGLN Sale 18,000 61.34 1,104,066
2013-11-13 MGLN Sale 46,541 59.82 2,784,222
2013-11-14 MGLN Sale 6,000 61.26 367,530
2013-11-11 MGLN Sale 4,000 59.16 236,628
2013-11-12 MGLN Sale 32,500 59.35 1,928,810
2013-11-07 MGLN Sale 8,000 59.72 477,752
2013-11-08 MGLN Sale 7,200 59.53 428,594
2013-11-06 MGLN Sale 86,500 59.29 5,128,325
2013-11-05 MGLN Sale 10,273 59.14 607,576
2013-11-01 MGLN Sale 22,000 58.46 1,286,054
2013-11-04 MGLN Sale 40,900 59.31 2,425,942
2013-03-05 MGLN Option Ex 7,046 .00 0
2013-03-03 MGLN Option Ex 7,372 .00 0
2012-03-03 MGLN Option Ex 8,265 .00 0
2012-03-03 MGLN Option Ex 15,638 .00 0
2012-03-04 MGLN Option Ex 9,298 .00 0
2011-10-10 MGLN Sale 3,750 50.05 187,702
2011-10-05 MGLN Sale 27,500 48.08 1,322,200
2011-10-03 MGLN Sale 10,000 48.29 482,900
2011-07-07 MGLN Sale 1,199 55.52 66,573
2011-07-05 MGLN Sale 40,051 55.02 2,203,445
2011-04-26 MGLN Sale 3,250 50.01 162,526
2011-04-08 MGLN Sale 7,000 49.91 349,335
2011-04-07 MGLN Sale 10,000 49.91 499,050
2011-04-06 MGLN Sale 21,000 49.92 1,048,341
2011-03-05 MGLN Option Ex 7,435 .00 0
2011-03-04 MGLN Option Ex 9,298 .00 0
2011-03-03 MGLN Option Ex 7,373 .00 0
2011-01-06 MGLN Sale 36,900 48.13 1,776,181
2011-01-03 MGLN Sale 600 48.07 28,842
2010-10-04 MGLN Sale 1,700 47.01 79,917
2010-10-05 MGLN Sale 700 47.35 33,145
2010-10-01 MGLN Sale 15,100 47.37 715,287
2010-07-30 MGLN Sale 17,500 40.73 712,757
2010-04-01 MGLN Sale 17,500 43.42 759,780
2010-03-05 MGLN Option Ex 7,435 .00 0
2010-03-04 MGLN Option Ex 9,298 .00 0
2010-03-02 MGLN Option Ex 7,266 .00 0
2010-01-04 MGLN Sale 17,500 41.39 724,377
2009-12-22 MGLN Sale 17,500 40.02 700,262
2009-03-05 MGLN Option Ex 7,435 .00 0
2009-03-02 MGLN Option Ex 7,267 .00 0
2009-02-24 MGLN Option Ex 5,623 .00 0
2008-03-03 MGLN Option Ex 7,267 .00 0
2008-02-25 MGLN Option Ex 5,623 .00 0
2007-02-24 MGLN Option Ex 5,623 .00 0
2007-01-18 MGLN Sale 47,900 41.19 1,972,857
2007-01-19 MGLN Sale 80,703 40.69 3,283,724
2007-01-17 MGLN Sale 26,400 42.27 1,115,928
2007-01-16 MGLN Sale 30,380 42.20 1,282,036
2007-01-12 MGLN Sale 28,100 41.90 1,177,446
2007-01-11 MGLN Sale 65,000 42.12 2,737,865
2007-01-10 MGLN Sale 145,000 14.47 2,097,860
2007-01-08 MGLN Sale 50,140 41.51 2,081,160
2007-01-09 MGLN Sale 63,550 41.17 2,616,671
2006-05-04 MGLN Sale 41,031 39.22 1,609,071

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lerer Rene (President & CEO of Magellan Health Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.